Using covariates to reduce uncertainty in the economic evaluation of clinical trial data
F. J. Vázquez‐Polo,
M. A. Negrín Hernández and
B. González López‐Valcárcel
Health Economics, 2005, vol. 14, issue 6, 545-557
Abstract:
As part of their practice, policymakers have to make economic evaluations using clinical trial data. Recent interest has been expressed in determining how cost‐effectiveness analysis can be undertaken in a regression framework. In this respect, published research basically provides a general method for prognostic factor adjustment in the presence of imbalance, emphasizing sub‐group analysis. In this paper, we present an alternative method from a Bayesian approach. We propose the use of covariates in Bayesian health technology assessment in order to reduce uncertainty about the effect of treatments. We show its advantages by comparison with another published method that do not adjust for covariates using simulated data. Copyright © 2004 John Wiley & Sons, Ltd.
Date: 2005
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (5)
Downloads: (external link)
https://doi.org/10.1002/hec.947
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:14:y:2005:i:6:p:545-557
Access Statistics for this article
Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones
More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().